Figure 6.
The antihyperalgesic mechanism of EA. EA treatment increases the amount of pCaMKII-PICK1 complexes. This prevents GluA1 phosphorylation, ultimately producing an anti-inflammatory pain effect.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.